Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines
Crossref DOI link: https://doi.org/10.1007/s00109-015-1338-3
Published Online: 2015-09-18
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wu, Yangping
Chen, Xiangzheng
Ge, Xiaojun
Xia, Hongwei
Wang, Yuxi
Su, Siyuan
Li, Wenting
Yang, Tinghan
Wei, Mingtian
Zhang, Hang
Gou, Lantu
Li, Jiong
Jiang, Xian
Yang, Jinliang
Text and Data Mining valid from 2015-09-18